Legal & General Group’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Legal & General Group’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-884	Closed	-$10K	–	3740
2022 Q1	$10K	Hold	884	–	–	﹤0.01%	3415
2021 Q4	$16K	Sell	884 -23	-3%	-$292	﹤0.01%	3358
2021 Q3	$11K	Hold	907	–	–	﹤0.01%	3440
2021 Q2	$16K	Buy	907 +251	+38%	+$4.77K	﹤0.01%	3370
2021 Q1	$12K	Sell	656 -71	-10%	-$1.49K	﹤0.01%	3338
2020 Q4	$14K	Hold	727	–	–	﹤0.01%	3229
2020 Q3	$15K	Sell	727 -165	-18%	-$3.86K	﹤0.01%	3091
2020 Q2	$26K	Hold	892	–	–	﹤0.01%	2960
2020 Q1	$31K	Sell	892 -228	-20%	-$7.38K	﹤0.01%	2753
2019 Q4	$27K	Buy	+1,120	New	+$19.7K	﹤0.01%	3100

Other funds holding OYST

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

IFA

Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

TAM

Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Legal & General Group's OYST Position: Q2 2022 in Review

Legal & General Group sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q2 2022, closing a stake of 884 shares — an estimated $10K sold.

Legal & General Group first reported a position in OYST in Q4 2019 and held it in 10 quarters. The position peaked at $31K in Q1 2020. 61 funds tracked by Wall St. Rank hold OYST as of Q2 2022.

Legal & General Group reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Legal & General Group sold 884 Oyster Point Pharma, Inc. Common Stock shares in Q2 2022, an estimated $10K.
Legal & General Group first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2019 and held it in 10 quarters.
Legal & General Group's Oyster Point Pharma, Inc. Common Stock position peaked at $31K in Q1 2020.
61 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q2 2022.

Based on Legal & General Group's 13F filing for Q2 2022, filed 22 Aug 2022.